Onder Law Wins 3rd Talcum Powder Ovarian Cancer Lawsuit for $70 Million, Onder’s 2016 Talcum Powder Ovarian Cancer Verdicts Top $197 Million
Onder Law Delivers Second Defeat to Johnson & Johnson in Baby Powder Ovarian Cancer Trial, Wins $55 Million for Client – May 2, 2016
Products Liability Litigation for Ovarian Cancer After Talcum Powder Use for Adult Feminine Hygiene
Talcum powder has been found to cause ovarian cancer among women who use it routinely for feminine hygiene. When dusted on the perineal region weekly, women face a 33% increase in risk for ovarian cancer. When used daily, the risk jumps by 41%, according to a 2008 study from Harvard epidemiologist Dr. Margaret Gates. Johnson & Johnson, the main producer of talc-based body powder and washes and leading cosmetic producer in the United States, has never warned women of the risk of talcum powder cancer. Another Harvard researcher, Dr. Daniel Cramer, asserts that as many as 10,000 women annually develop ovarian cancer from using talcum powder. Ovarian cancer is a dangerous disease that is projected to cause 14,000 American deaths in 2014.
Understanding the Talcum Powder Cancer Link
Research published in the last decade confirms long-held suspicions that dusting the genital area with talcum powder increases a woman’s risk for ovarian cancer. When talc particles into the female reproductive system, they can migrate to the ovaries. Talc is slow to break down, and can remain intact in the ovaries for years. Here the foreign particles create an inflammatory response, creating conditions which increase the likelihood of cancer growth.
Talcum Powder Cancer Lawsuits
As evidence regarding the talcum powder cancer connection has become mainstream in recent years, women are learning that their cancer diagnosis may be linked to their regular use of talcum powder. Never warned of the danger, these women are rightfully angry. Johnson & Johnson is now facing lawsuits throughout the United States based on its failure to warn consumers of the talcum powder cancer risk.
The first talcum powder ovarian cancer lawsuit was won in a North Dakota federal court in 2013. One attorney representing J&J conceded that company executives had been aware of the baby powder ovarian cancer link for years but did not deem the risk significant enough to require a product warning. Meanwhile, the company has marketed talcum powder products widely, and dominate this sector of the cosmetics market. Women and the families of women who have suffered from ovarian cancer have a right to litigate against the company in order to seek justice.
Talcum Powder Cancer Lawyers
Individuals and the family members of persons who were diagnosed with ovarian cancer after using talcum powder may be entitled to real compensation through a talcum powder cancer lawsuit. Our attorneys provide free talcum powder claim reviews, and will be happy to answer your questions and help you to understand your legal options. All talcum powder cancer lawsuit services are provided on a contingency basis, meaning there are no legal fees unless we win compensation on your behalf.
Filing a lawsuit is the best means for individual consumers to hold pharmaceutical companies accountable for harmful products. By placing profit motives ahead of consumer safety, the makers of talcum powder have caused undue harm and loss to Americans and their families while reaping the benefits of product sales. Negligent and unscrupulous pharmaceutical companies can, and should, be held accountable for their actions, and injured consumers have a right to seek justice. Filing a talcum powder lawsuit enables consumers to hold the companies accountable for the safety of their products.
OnderLaw, LLC has a national reputation for its work in family and consumer safety based on an ethic of hard work, reliable advice, and achieving results on behalf of our clients. We will work tirelessly to ensure each of our clients has trustworthy and excellent legal representation. Contact our attorneys to ensure you have an experienced advocate fighting on behalf of your family.